Total planned funding: $374,415,681
Clear active filters
Abt Associates
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Mozambique | $125,205,078 |
| Ethiopia | $56,477,750 |
| Zambia | $42,050,731 |
| Tanzania | $36,750,783 |
| Côte d'Ivoire | $24,823,360 |
| Vietnam | $15,396,488 |
| Namibia | $12,392,713 |
| Kenya | $10,422,000 |
| Nigeria | $8,452,484 |
| Zimbabwe | $7,660,000 |
| Caribbean Region | $6,131,141 |
| Haiti | $3,990,000 |
| Eswatini | $3,955,000 |
| Malawi | $3,932,024 |
| Central Asia Region | $3,632,129 |
| Botswana | $3,150,000 |
| South Africa | $2,000,000 |
| Dominican Republic | $1,975,000 |
| Burundi | $1,225,000 |
| Cambodia | $850,000 |
| Democratic Republic of the Congo | $700,000 |
| Ukraine | $600,000 |
| Asia Regional Program | $600,000 |
| South Sudan | $590,000 |
| Rwanda | $500,000 |
| Indonesia | $480,000 |
| Uganda | $274,000 |
| India | $200,000 |
Organizational Types
| Private Contractor | $374,415,681 |
Program Areas
| Governance and Systems | $146,080,987 |
| Treatment | $97,256,269 |
| Prevention | $51,562,600 |
| Care | $48,636,100 |
| Testing | $16,814,359 |
Budget Codes
| OHSS: Health Systems Strengthening | $125,365,018 |
| HTXS: Treatment: Adult Treatment | $87,638,977 |
| HBHC: Care: Adult Care and Support | $21,832,743 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $21,436,318 |
| HVSI: Strategic Information | $19,300,918 |
| HVCT: Testing: HIV Testing and Counseling | $16,814,359 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $12,120,155 |
| PDCS: Care: Pediatric Care and Support | $11,942,835 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $10,901,749 |
| PDTX: Treatment: Pediatric Treatment | $9,482,939 |
| HVTB: Care: TB/HIV | $8,556,999 |
| HKID: Care: Orphans and Vulnerable Children | $6,303,523 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,736,761 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,144,830 |
| HLAB: Laboratory Infrastructure | $1,415,051 |
| HMIN: Biomedical Prevention: Injection Safety | $222,787 |
| HTXD: Treatment: ARV Drugs | $134,353 |
| HMBL: Biomedical Prevention: Blood Safety | $0 |
Top Partner Programs
Abt Associates:
$374,415,681
View countries